Bioceres Crop Solutions's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Bioceres Crop Solutions (BIOX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Bioceres Crop Solutions vs Its Competitors
- TTM: Trailing 12-month revenue of 335M vs 21,063M combined for tracked competitors (1.6% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-11.9% annualized vs trailing 12 months), vs accelerating (+42.6%) for its tracked peer group.
- Growth: Bioceres Crop Solutions generated -25.3% revenue growth year over year in Q4 2025, vs 5.0% for its tracked competitors combined.
- Profitability: Its -247.2% net margin compares with 18.4% for the peer group.
- Scale: Bioceres Crop Solutions ranks #27 of 45 companies by market capitalization in the Agricultural Production industry, holding 0.0% of industry market cap.
- Peer revenue share: Bioceres Crop Solutions accounted for 1.0% of combined revenue among its tracked peer group, down from 1.4% a year earlier.
- Peer differentiation: Revenue per employee of $4.72M compares with $0.78M for the peer group (6.1x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
BIOX Sales vs. its Competitors, Q4 2025
Bioceres Crop Solutions reported revenue contraction of 25.30 % year on year in Q4 2025, below its competitors' combined revenue growth of 4.98 %.
With a net margin of -247.23 %, Bioceres Crop Solutions reported lower profitability than its competitors (18.43 %).
Bioceres Crop Solutions generated 0.97 % of the combined sales of its peer group, down from 1.36 % a year earlier.
Bioceres Crop Solutions vs. its Competitors, Q4 2025
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Bioceres Crop Solutions and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Bioceres Crop Solutions Corp | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (3) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (9) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Bioceres Crop Solutions's competitor groups requires a Commercial License.
For context: the Agricultural Production industry grew revenue 16.8% year over year, combined, vs -25.3% for Bioceres Crop Solutions. Bioceres Crop Solutions's share of combined industry revenue moved from 0.10% to 0.06%, a loss of 0.04 percentage points.
Bioceres Crop Solutions's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Bioceres Crop Solutions Corp | - | - | - | - |
| Competitors combined (3) | ||||
| High-Confidence Competitors (4) | ||||
| Similar-Size Competitors (10) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
BIOX Stock Performance relative to its Competitors
BIOX Stock Performance relative to High-Confidence Competitors
BIOX Stock Performance relative to Similar-Size Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Corteva Inc | 282.9% | Outperformed |
| 2 | Fmc Corporation | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Bioceres Crop Solutions's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Bioceres Crop Solutions's Comment on Competition and Industry Peers
Publicly Traded Peers of Bioceres Crop Solutions Corp
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Bioceres Crop Solutions Corp | 21.54 | 335.11 |
| Corteva Inc | 51,809.03 | 17,812.00 |
| Fmc Corporation | 1,136.79 | 3,251.20 |
| Talis Biomedical Corporation | 29.16 | 2.85 |
| SUBTOTAL | 52,996.52 | 21,401.16 |
Sources: Bioceres Crop Solutions Corp's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Bioceres Crop Solutions Corp versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Bioceres Crop Solutions's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Corteva | Named by the company | 85% |
| Gowan | Named by the company | 85% |
| Recuperar | Named by the company | 85% |
| UPL | Named by the company | 85% |
| BASF | Named by the company | 85% |
| BioSAfe Systems | Named by the company | 85% |
| FMC | Named by the company | 85% |
| Novozymes | Named by the company | 85% |
| Sumitomo Corporation | Named by the company | 85% |
| Biagro | Named by the company | 85% |
| Don Mario | Named by the company | 85% |
| Nitragin | Named by the company | 85% |
| Red Surcos | Named by the company | 85% |
| Valagro | Named by the company | 85% |
| Bayer | Named by the company | 85% |
| Certis Biologicals | Named by the company | 85% |
| FYO | Named by the company | 85% |
| Pro Farm | Named by the company | 85% |
| Syngenta | Named by the company | 85% |
| Bioceres S.A. | Named by the company | 85% |
| Evogene Ltd. | Named by the company | 85% |
| Nova | Named by the company | 85% |
| Rizobacter | Named by the company | 85% |
| Valent Biosciences | Named by the company | 85% |
| Becker Underwood | Named by the company | 85% |
| Fmc Corporation | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Bioceres Crop Solutions's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Bioceres Crop Solutions's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Corteva Inc | Seed 71.05 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Bioceres Crop Solutions's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Bioceres Crop Solutions Corp | 22 | 4,719,843 | -828,806 |
| Corteva Inc | 51,809 | 828,465 | 47,488 |
| Fmc Corporation | 1,137 | 591,127 | -501,291 |
| Talis Biomedical Corporation | 29 | 44,563 | -797,281 |
| PEERS TOTAL | 52,975 | 778,379 | -66,033 |
Bioceres Crop Solutions's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Fmc Corporation | EMEA 40.46 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Bioceres Crop Solutions's Position in Industry Market Structure
Market-capitalization share and concentration across all 39 companies in Bioceres Crop Solutions's industry classification, broader than the peer set above. Market cap in millions of $.Bioceres Crop Solutions ranks #27 of 39 companies by market capitalization in its industry, holding 0.01 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,559, indicating a moderately concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Archer daniels midland Co | 38,509 | 25.08 % |
| 2 | Nutrien Ltd | 34,630 | 22.56 % |
| 3 | Bunge Global Sa | 21,167 | 13.79 % |
| 4 | Cf Industries Holdings inc | 17,806 | 11.60 % |
| 5 | Darling Ingredients Inc | 1,234 | 5.2% |
| 6 | Mosaic Co | 1,234 | 5.2% |
| 7 | Icl Group Ltd | 1,234 | 5.2% |
| 8 | Seaboard Corporation | 1,234 | 5.2% |
| 9 | Scotts Miracle gro Co | 1,234 | 5.2% |
| 10 | Andersons Inc | 1,234 | 5.2% |
| 27 | Bioceres Crop Solutions Corp | 22 | 0.01 % |
Market cap and industry share for the rest of Bioceres Crop Solutions's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-29.
Bioceres Crop Solutions's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 22 | Cibus Inc | 119 | 13.08 % |
| 23 | Golden Growers Cooperative | 77 | - |
| 24 | American Vanguard Corporation | 51 | -68.68 % |
| 25 | Rythm Inc | 48 | -38.76 % |
| 26 | Local Bounti Corporation | 1,234 | 12.3% |
| 27 | Bioceres Crop Solutions Corp | 22 | -76.65 % |
| 28 | Cavitation Technologies Inc | 1,234 | 12.3% |
| 29 | Australian Oilseeds Holdings Limited | 1,234 | 12.3% |
| 30 | Bion Environmental Technologies Inc | 1,234 | 12.3% |
| 31 | Origin Agritech Limited | 1,234 | 12.3% |
| 32 | Bloomia Holdings inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Bioceres Crop Solutions's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-29. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Bioceres Crop Solutions's BCG Growth-Share Matrix
Relative market share (vs Bioceres Crop Solutions's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Bioceres Crop Solutions falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 4.2% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Bioceres Crop Solutions's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Moderate | Industry HHI of 1,559 (see Industry Market Structure & Concentration above) |
| Supplier Power | Not covered on this page | See Bioceres Crop Solutions's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Bioceres Crop Solutions's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Bioceres Crop Solutions's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Bioceres Crop Solutions falls in the Low attractiveness / Low strength cell: Harvest / Divest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Bioceres Crop Solutions's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Latest-quarter revenue run-rate is decelerating (-11.9% annualized vs trailing 12 months).
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.00x).
Opportunities
- A meaningful share of tracked competitors (50.00 %) show financial-distress signals, a possible opening to gain share.
Threats
No rule matched.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Bioceres Crop Solutions's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Bioceres Crop Solutions Corp | 0.10 | 0.91 | 0.13 |
| Corteva Inc | 0.25 | 1.49 | 0.15 |
| Fmc Corporation | 0.14 | 1.45 | 1.85 |
| Talis Biomedical Corporation | 8.45 | 8.66 | - |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Bioceres Crop Solutions's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Bioceres Crop Solutions Corp | Q2 2025 | -27.9 % | - |
| Corteva Inc | Q2 2026 | -1.2 % | -11.5 % |
| Fmc Corporation | Q2 2026 | -17.5 % | - |
| Talis Biomedical Corporation | Q2 2024 | - | - |
| PEERS TOTAL | -4.9 % | -33.8 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Bioceres Crop Solutions's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Bioceres Crop Solutions Corp | Q2 2025 | -26.9 % | -42.4 % |
| Corteva Inc | Q2 2026 | -7.3 % | +3.4 % |
| Fmc Corporation | Q2 2026 | -18.5 % | -64.7 % |
| Talis Biomedical Corporation | Q2 2024 | - | - |
Bioceres Crop Solutions's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Bioceres Crop Solutions Corp | - | - | - |
| Corteva Inc | 2.41% | 3.42% | 4.09% |
| Fmc Corporation | - | - | - |
| Talis Biomedical Corporation | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Bioceres Crop Solutions's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Bioceres Crop Solutions Corp | - | 0.06 |
| Corteva Inc | 50.81 | 2.91 |
| Fmc Corporation | - | 0.35 |
| Talis Biomedical Corporation | - | 10.22 |
| PEERS AVERAGE | - | 2.48 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.